Apple, Inc AAPL
S&P 500 ETF Trust SPDR SPY
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

Adarx pharmaceuticals, inc. common stock share price

ADRX

NSQ

$17.33

-$1.25

(-6.73%)

Adarx pharmaceuticals, inc. common stock analyst forecast

Overview Returns Financials Ratios News Faqs

Adarx pharmaceuticals, inc. common stock share price chart

Adarx pharmaceuticals, inc. common stock key stock metrics

Market Cap

This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.

$1.98B

P/E Ratio

This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.

Volume

This is the total number of shares traded during the most recent trading day.

705.70K

Avg Volume

This is the average number of shares traded during the most recent 30 days.

Dividend Yield

This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).

0.00%

Beta

This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.

52-week Range

This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

$17.3 L

$23.21 H

$17.33

About adarx pharmaceuticals, inc. common stock, common stock

ADARx Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on developing siRNA therapeutics to treat a broad spectrum of diseases. The company offers hepatic-targeted programs, including Agazisiran, a complement factor B (CFB) program that represents a pipeline-in-a-product opportunity, where a single therapeutic candidate has the potential to address multiple indications; Onvuzosiran, a clinical program for the prevention of HAE attacks; and ADX-626, a Factor XI (FXI) program for secondary stroke prevention with additional clinical potential for stroke prevention in atrial fibrillation. It also offers extrahepatic-targeted programs, such as ADX-077, an adipose-targeted obesity program designed to reduce body weight and fat while preserving lean mass; and ADX-199, a neuron-targeted program designed to selectively silence and degrade amyloid-ß precursor protein (APP) mRNA in neurons, which is genetically linked to Alzheimer's disease. The company was incorporated in 2019 and is based in San Diego, California. more

Adarx pharmaceuticals, inc. common stock stock returns

Data is not properly formatted.

Time Frame	ADRX		S&P500
1-Week Return	-6.82%%	%	2.19%%
1-Month Return	-3.98%%	%	1.72%%

Adarx pharmaceuticals, inc. common stock financials

	Dec '24	Dec '25
Total Revenue	-	3.45M	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":100,"profit":true}]
Cost of Revenue	-	-	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Gross Profit	-	-	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Gross Margin	-	-	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}]

Operating Expenses	58.23M	91.81M	[{"date":"2024-12-31","value":63.42,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]
Operating Income	(58.23M)	(88.36M)	[{"date":"2024-12-31","value":-5823300000,"profit":false},{"date":"2025-12-31","value":-8836500000,"profit":false}]
Total Non-Operating Income/Expense	11.87M	15.28M	[{"date":"2024-12-31","value":77.72,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]
Pre-Tax Income	(46.36M)	(73.09M)	[{"date":"2024-12-31","value":-4636000000,"profit":false},{"date":"2025-12-31","value":-7308800000,"profit":false}]
Income Taxes	-	-	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Income After Taxes	-	-	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}]

Income From Continuous Operations	(46.36M)	(73.09M)	[{"date":"2024-12-31","value":-4636000000,"profit":false},{"date":"2025-12-31","value":-7308800000,"profit":false}]
Income From Discontinued Operations	-	-	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Net Income	(46.36M)	(73.09M)	[{"date":"2024-12-31","value":-4636000000,"profit":false},{"date":"2025-12-31","value":-7308800000,"profit":false}]

EPS (Diluted)	-	-	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}]

	Dec '24	Dec '25
Total Revenue	-	-	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Cost of Revenue	-	-	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Gross Profit	-	-	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Gross Margin	-	-	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}]

Operating Expenses	-	57.67%	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":100,"profit":true}]
Operating Income	-	51.74%	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":100,"profit":true}]
Total Non-Operating Income/Expense	-	28.67%	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":100,"profit":true}]
Pre-Tax Income	-	57.65%	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":100,"profit":true}]
Income Taxes	-	-	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Income After Taxes	-	-	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}]

Income From Continuous Operations	-	57.65%	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":100,"profit":true}]
Income From Discontinued Operations	-	-	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Net Income	-	57.65%	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":100,"profit":true}]

EPS (Diluted)	-	-	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}]

	Mar '25	Jun '25	Mar '26	Jun '26
Total Revenue	-	208.00K	2.14M	746.00K	[{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":9.72,"profit":true},{"date":"2026-03-31","value":100,"profit":true},{"date":"2026-06-30","value":34.86,"profit":true}]
Cost of Revenue	-	-	-	-	[{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2026-03-31","value":"-","profit":true},{"date":"2026-06-30","value":"-","profit":true}]
Gross Profit	-	-	-	-	[{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2026-03-31","value":"-","profit":true},{"date":"2026-06-30","value":"-","profit":true}]
Gross Margin	-	-	-	-	[{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2026-03-31","value":"-","profit":true},{"date":"2026-06-30","value":"-","profit":true}]

Operating Expenses	17.89M	21.33M	29.20M	30.64M	[{"date":"2025-03-31","value":58.39,"profit":true},{"date":"2025-06-30","value":69.62,"profit":true},{"date":"2026-03-31","value":95.3,"profit":true},{"date":"2026-06-30","value":100,"profit":true}]
Operating Income	(17.89M)	(21.12M)	(27.06M)	(29.89M)	[{"date":"2025-03-31","value":-1788800000,"profit":false},{"date":"2025-06-30","value":-2112200000,"profit":false},{"date":"2026-03-31","value":-2705600000,"profit":false},{"date":"2026-06-30","value":-2989100000,"profit":false}]
Total Non-Operating Income/Expense	2.34M	3.03M	4.39M	4.13M	[{"date":"2025-03-31","value":53.25,"profit":true},{"date":"2025-06-30","value":69.01,"profit":true},{"date":"2026-03-31","value":100,"profit":true},{"date":"2026-06-30","value":94.14,"profit":true}]
Pre-Tax Income	(15.55M)	(18.09M)	(22.67M)	(25.76M)	[{"date":"2025-03-31","value":-1555100000,"profit":false},{"date":"2025-06-30","value":-1809300000,"profit":false},{"date":"2026-03-31","value":-2266700000,"profit":false},{"date":"2026-06-30","value":-2575900000,"profit":false}]
Income Taxes	-	-	-	-	[{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2026-03-31","value":"-","profit":true},{"date":"2026-06-30","value":"-","profit":true}]
Income After Taxes	-	-	-	-	[{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2026-03-31","value":"-","profit":true},{"date":"2026-06-30","value":"-","profit":true}]

Income From Continuous Operations	(15.55M)	(18.09M)	(22.67M)	(25.76M)	[{"date":"2025-03-31","value":-1555100000,"profit":false},{"date":"2025-06-30","value":-1809300000,"profit":false},{"date":"2026-03-31","value":-2266700000,"profit":false},{"date":"2026-06-30","value":-2575900000,"profit":false}]
Income From Discontinued Operations	-	-	-	-	[{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2026-03-31","value":"-","profit":true},{"date":"2026-06-30","value":"-","profit":true}]
Net Income	(15.55M)	(18.09M)	(22.67M)	(25.76M)	[{"date":"2025-03-31","value":-1555100000,"profit":false},{"date":"2025-06-30","value":-1809300000,"profit":false},{"date":"2026-03-31","value":-2266700000,"profit":false},{"date":"2026-06-30","value":-2575900000,"profit":false}]

EPS (Diluted)	-	-	-	-	[{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2026-03-31","value":"-","profit":true},{"date":"2026-06-30","value":"-","profit":true}]

	Mar '25	Jun '25	Mar '26	Jun '26
Total Revenue	-	-	928.85%	(65.14%)	[{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2026-03-31","value":100,"profit":true},{"date":"2026-06-30","value":-7.01,"profit":false}]
Cost of Revenue	-	-	-	-	[{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2026-03-31","value":"-","profit":true},{"date":"2026-06-30","value":"-","profit":true}]
Gross Profit	-	-	-	-	[{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2026-03-31","value":"-","profit":true},{"date":"2026-06-30","value":"-","profit":true}]
Gross Margin	-	-	-	-	[{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2026-03-31","value":"-","profit":true},{"date":"2026-06-30","value":"-","profit":true}]

Operating Expenses	-	19.24%	36.88%	4.94%	[{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":52.18,"profit":true},{"date":"2026-03-31","value":100,"profit":true},{"date":"2026-06-30","value":13.38,"profit":true}]
Operating Income	-	18.08%	28.09%	10.48%	[{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":64.35,"profit":true},{"date":"2026-03-31","value":100,"profit":true},{"date":"2026-06-30","value":37.3,"profit":true}]
Total Non-Operating Income/Expense	-	29.61%	44.90%	(5.86%)	[{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":65.95,"profit":true},{"date":"2026-03-31","value":100,"profit":true},{"date":"2026-06-30","value":-13.04,"profit":false}]
Pre-Tax Income	-	16.35%	25.28%	13.64%	[{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":64.66,"profit":true},{"date":"2026-03-31","value":100,"profit":true},{"date":"2026-06-30","value":53.96,"profit":true}]
Income Taxes	-	-	-	-	[{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2026-03-31","value":"-","profit":true},{"date":"2026-06-30","value":"-","profit":true}]
Income After Taxes	-	-	-	-	[{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2026-03-31","value":"-","profit":true},{"date":"2026-06-30","value":"-","profit":true}]

Income From Continuous Operations	-	16.35%	25.28%	13.64%	[{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":64.66,"profit":true},{"date":"2026-03-31","value":100,"profit":true},{"date":"2026-06-30","value":53.96,"profit":true}]
Income From Discontinued Operations	-	-	-	-	[{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2026-03-31","value":"-","profit":true},{"date":"2026-06-30","value":"-","profit":true}]
Net Income	-	16.35%	25.28%	13.64%	[{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":64.66,"profit":true},{"date":"2026-03-31","value":100,"profit":true},{"date":"2026-06-30","value":53.96,"profit":true}]

EPS (Diluted)	-	-	-	-	[{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2026-03-31","value":"-","profit":true},{"date":"2026-06-30","value":"-","profit":true}]

	Dec '24	Dec '25
Total Assets
Current Assets	225.67M	493.38M	[{"date":"2024-12-31","value":45.74,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]
Non-current Assets	7.79M	14.28M	[{"date":"2024-12-31","value":54.53,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]
Total Assets	233.45M	507.65M	[{"date":"2024-12-31","value":45.99,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]

Total Liabilities
Current Liabilities	8.94M	30.48M	[{"date":"2024-12-31","value":29.32,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]
Non-current Liabilities	361.66M	679.42M	[{"date":"2024-12-31","value":53.23,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]
Total Liabilities	370.60M	709.91M	[{"date":"2024-12-31","value":52.2,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	-	-	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Retained Earnings	(147.61M)	(220.70M)	[{"date":"2024-12-31","value":-14761100000,"profit":false},{"date":"2025-12-31","value":-22069900000,"profit":false}]
Other Stockholders' Equity	-	-	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Total Shareholders' equity	(137.15M)	(202.25M)	[{"date":"2024-12-31","value":-13714500000,"profit":false},{"date":"2025-12-31","value":-20225500000,"profit":false}]

Total Liabilities & Shareholders Equity	233.45M	507.65M	[{"date":"2024-12-31","value":45.99,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]

	Dec '24	Dec '25
Total Assets
Current Assets	-	118.63%	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":100,"profit":true}]
Non-current Assets	-	83.38%	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":100,"profit":true}]
Total Assets	-	117.45%	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":100,"profit":true}]

Total Liabilities
Current Liabilities	-	241.11%	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":100,"profit":true}]
Non-current Liabilities	-	87.86%	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":100,"profit":true}]
Total Liabilities	-	91.56%	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	-	-	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Retained Earnings	-	49.51%	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":100,"profit":true}]
Other Stockholders' Equity	-	-	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Total Shareholders' equity	-	47.48%	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":100,"profit":true}]

Total Liabilities & Shareholders Equity	-	117.45%	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":100,"profit":true}]

	Dec '25	Mar '26	Jun '26
Total Assets
Current Assets	493.38M	468.72M	441.54M	[{"date":"2025-12-31","value":100,"profit":true},{"date":"2026-03-31","value":95,"profit":true},{"date":"2026-06-30","value":89.49,"profit":true}]
Non-current Assets	14.28M	13.84M	14.79M	[{"date":"2025-12-31","value":96.56,"profit":true},{"date":"2026-03-31","value":93.57,"profit":true},{"date":"2026-06-30","value":100,"profit":true}]
Total Assets	507.65M	482.56M	456.33M	[{"date":"2025-12-31","value":100,"profit":true},{"date":"2026-03-31","value":95.06,"profit":true},{"date":"2026-06-30","value":89.89,"profit":true}]

Total Liabilities
Current Liabilities	30.48M	29.75M	34.01M	[{"date":"2025-12-31","value":89.63,"profit":true},{"date":"2026-03-31","value":87.48,"profit":true},{"date":"2026-06-30","value":100,"profit":true}]
Non-current Liabilities	679.42M	678.53M	673.37M	[{"date":"2025-12-31","value":100,"profit":true},{"date":"2026-03-31","value":99.87,"profit":true},{"date":"2026-06-30","value":99.11,"profit":true}]
Total Liabilities	709.91M	708.29M	707.38M	[{"date":"2025-12-31","value":100,"profit":true},{"date":"2026-03-31","value":99.77,"profit":true},{"date":"2026-06-30","value":99.64,"profit":true}]

Total Shareholders' equity
Common Stock	-	-	-	[{"date":"2025-12-31","value":"-","profit":true},{"date":"2026-03-31","value":"-","profit":true},{"date":"2026-06-30","value":"-","profit":true}]
Retained Earnings	(220.70M)	(243.37M)	(269.13M)	[{"date":"2025-12-31","value":-22069900000,"profit":false},{"date":"2026-03-31","value":-24336600000,"profit":false},{"date":"2026-06-30","value":-26912500000,"profit":false}]
Other Stockholders' Equity	-	-	-	[{"date":"2025-12-31","value":"-","profit":true},{"date":"2026-03-31","value":"-","profit":true},{"date":"2026-06-30","value":"-","profit":true}]
Total Shareholders' equity	(202.25M)	(225.73M)	(251.05M)	[{"date":"2025-12-31","value":-20225500000,"profit":false},{"date":"2026-03-31","value":-22573200000,"profit":false},{"date":"2026-06-30","value":-25105200000,"profit":false}]

Total Liabilities & Shareholders Equity	507.65M	482.56M	456.33M	[{"date":"2025-12-31","value":100,"profit":true},{"date":"2026-03-31","value":95.06,"profit":true},{"date":"2026-06-30","value":89.89,"profit":true}]

	Dec '25	Mar '26	Jun '26
Total Assets
Current Assets	-	(5.00%)	(5.80%)	[{"date":"2025-12-31","value":"-","profit":true},{"date":"2026-03-31","value":null,"profit":false},{"date":"2026-06-30","value":null,"profit":false}]
Non-current Assets	-	(3.10%)	6.87%	[{"date":"2025-12-31","value":"-","profit":true},{"date":"2026-03-31","value":-45.04,"profit":false},{"date":"2026-06-30","value":100,"profit":true}]
Total Assets	-	(4.94%)	(5.43%)	[{"date":"2025-12-31","value":"-","profit":true},{"date":"2026-03-31","value":null,"profit":false},{"date":"2026-06-30","value":null,"profit":false}]

Total Liabilities
Current Liabilities	-	(2.39%)	14.31%	[{"date":"2025-12-31","value":"-","profit":true},{"date":"2026-03-31","value":-16.73,"profit":false},{"date":"2026-06-30","value":100,"profit":true}]
Non-current Liabilities	-	(0.13%)	(0.76%)	[{"date":"2025-12-31","value":"-","profit":true},{"date":"2026-03-31","value":null,"profit":false},{"date":"2026-06-30","value":null,"profit":false}]
Total Liabilities	-	(0.23%)	(0.13%)	[{"date":"2025-12-31","value":"-","profit":true},{"date":"2026-03-31","value":null,"profit":false},{"date":"2026-06-30","value":null,"profit":false}]

Total Shareholders' equity
Common Stock	-	-	-	[{"date":"2025-12-31","value":"-","profit":true},{"date":"2026-03-31","value":"-","profit":true},{"date":"2026-06-30","value":"-","profit":true}]
Retained Earnings	-	10.27%	10.58%	[{"date":"2025-12-31","value":"-","profit":true},{"date":"2026-03-31","value":97.03,"profit":true},{"date":"2026-06-30","value":100,"profit":true}]
Other Stockholders' Equity	-	-	-	[{"date":"2025-12-31","value":"-","profit":true},{"date":"2026-03-31","value":"-","profit":true},{"date":"2026-06-30","value":"-","profit":true}]
Total Shareholders' equity	-	11.61%	11.22%	[{"date":"2025-12-31","value":"-","profit":true},{"date":"2026-03-31","value":100,"profit":true},{"date":"2026-06-30","value":96.63,"profit":true}]

Total Liabilities & Shareholders Equity	-	(4.94%)	(5.43%)	[{"date":"2025-12-31","value":"-","profit":true},{"date":"2026-03-31","value":null,"profit":false},{"date":"2026-06-30","value":null,"profit":false}]

	Dec '24	Dec '25
Operating Activities
Net Operating Cash Flow	(48.56M)	262.29M	[{"date":"2024-12-31","value":-18.52,"profit":false},{"date":"2025-12-31","value":100,"profit":true}]

Investing Activities
Net Investing Cash Flow	-	-	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	225.00K	97.00K	[{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":43.11,"profit":true}]

Net Change in Cash	(8.82M)	52.48M	[{"date":"2024-12-31","value":-16.8,"profit":false},{"date":"2025-12-31","value":100,"profit":true}]

Free Cash Flow
Free Cash Flow	(49.02M)	259.35M	[{"date":"2024-12-31","value":-18.9,"profit":false},{"date":"2025-12-31","value":100,"profit":true}]

	Dec '24	Dec '25
Operating Activities
Net Operating Cash Flow	-	(640.10%)	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":null,"profit":false}]

Investing Activities
Net Investing Cash Flow	-	-	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	-	(56.89%)	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":null,"profit":false}]

Net Change in Cash	-	(695.18%)	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":null,"profit":false}]

Free Cash Flow
Free Cash Flow	-	(629.10%)	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":null,"profit":false}]

	Mar '25	Jun '25	Mar '26	Jun '26
Operating Activities
Net Operating Cash Flow	(12.71M)	313.44M	(22.68M)	(27.19M)	[{"date":"2025-03-31","value":-4.05,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2026-03-31","value":-7.24,"profit":false},{"date":"2026-06-30","value":-8.67,"profit":false}]

Investing Activities
Net Investing Cash Flow	-	-	-	-	[{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2026-03-31","value":"-","profit":true},{"date":"2026-06-30","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	-	83.00K	2.00K	6.00K	[{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2026-03-31","value":2.41,"profit":true},{"date":"2026-06-30","value":7.23,"profit":true}]

Net Change in Cash	1.23M	50.38M	(2.66M)	(5.37M)	[{"date":"2025-03-31","value":2.44,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2026-03-31","value":-5.28,"profit":false},{"date":"2026-06-30","value":-10.67,"profit":false}]

Free Cash Flow
Free Cash Flow	(13.20M)	312.45M	(22.76M)	(27.56M)	[{"date":"2025-03-31","value":-4.23,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2026-03-31","value":-7.28,"profit":false},{"date":"2026-06-30","value":-8.82,"profit":false}]

	Mar '25	Jun '25	Mar '26	Jun '26
Operating Activities
Net Operating Cash Flow	-	(2567.09%)	(107.24%)	19.89%	[{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":-12906.59,"profit":false},{"date":"2026-03-31","value":-539.15,"profit":false},{"date":"2026-06-30","value":100,"profit":true}]

Investing Activities
Net Investing Cash Flow	-	-	-	-	[{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2026-03-31","value":"-","profit":true},{"date":"2026-06-30","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	-	-	(97.59%)	200.00%	[{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2026-03-31","value":-48.8,"profit":false},{"date":"2026-06-30","value":100,"profit":true}]

Net Change in Cash	-	3992.61%	(105.28%)	102.11%	[{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2026-03-31","value":-2.64,"profit":false},{"date":"2026-06-30","value":2.56,"profit":true}]

Free Cash Flow
Free Cash Flow	-	(2466.70%)	(107.28%)	21.10%	[{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":-11692.3,"profit":false},{"date":"2026-03-31","value":-508.53,"profit":false},{"date":"2026-06-30","value":100,"profit":true}]

Adarx pharmaceuticals, inc. common stock ratios

Adarx pharmaceuticals, inc. common stock liquidity ratios

These ratios help you determine the liquidity of the company. Higher is better.

	ADRX
Current Ratio	12.98

Adarx pharmaceuticals, inc. common stock asset efficiency ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

	ADRX
ROA (LTM)	0.00%
ROE (LTM)	0.00%

Adarx pharmaceuticals, inc. common stock liability ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

	ADRX
Debt Ratio Lower is generally better. Negative is bad.	1.55
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier.	-0.55

Adarx pharmaceuticals, inc. common stock valuation ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

	ADRX
Trailing PE	NM
Forward PE	NM
P/S (TTM)	323.87
P/B	0.00
Price/FCF	NM
EV/R	0.00
EV/Ebitda	NM

Discover more

Tesla, Inc.

Apple, Inc.

Alphabet Inc. - Class A Shares

Meta Platforms Inc

Amazon.com Inc.

Microsoft Corporation

NVIDIA Corporation

Berkshire Hathaway Inc. Hld B

Eli Lilly and Company

Faqs

What is ADARx Pharmaceuticals, Inc. Common Stock share price today?

ADARx Pharmaceuticals, Inc. Common Stock (ADRX) share price today is $17.33

Can Indians buy ADARx Pharmaceuticals, Inc. Common Stock shares?

Yes, Indians can buy shares of ADARx Pharmaceuticals, Inc. Common Stock (ADRX) on Vested. To buy from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in ADRX stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of ADARx Pharmaceuticals, Inc. Common Stock be purchased?

Yes, you can purchase fractional shares of ADARx Pharmaceuticals, Inc. Common Stock (ADRX) via the Vested app. You can start investing in ADARx Pharmaceuticals, Inc. Common Stock (ADRX) with a minimum investment of $1.

How to invest in ADARx Pharmaceuticals, Inc. Common Stock shares from India?

You can invest in shares of ADARx Pharmaceuticals, Inc. Common Stock (ADRX) via Vested in three simple steps:

Click on Sign Up or Invest in ADRX stock at the top of this page
Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
Transfer USD funds to your US Brokerage account and start investing in ADARx Pharmaceuticals, Inc. Common Stock shares

What is ADARx Pharmaceuticals, Inc. Common Stock 52-week high and low stock price?

The 52-week high price of ADARx Pharmaceuticals, Inc. Common Stock (ADRX) is $23.21. The 52-week low price of ADARx Pharmaceuticals, Inc. Common Stock (ADRX) is $17.3.

What is ADARx Pharmaceuticals, Inc. Common Stock price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of ADARx Pharmaceuticals, Inc. Common Stock (ADRX) is

What is ADARx Pharmaceuticals, Inc. Common Stock price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of ADARx Pharmaceuticals, Inc. Common Stock (ADRX) is 0.00

What is ADARx Pharmaceuticals, Inc. Common Stock dividend yield?

The dividend yield of ADARx Pharmaceuticals, Inc. Common Stock (ADRX) is 0.00%

What is the Market Cap of ADARx Pharmaceuticals, Inc. Common Stock?

The market capitalization of ADARx Pharmaceuticals, Inc. Common Stock (ADRX) is $1.98B

What is ADARx Pharmaceuticals, Inc. Common Stock's stock symbol?

The stock symbol (or ticker) of ADARx Pharmaceuticals, Inc. Common Stock is ADRX

How Can Investors Use ADARx Pharmaceuticals, Inc. Common Stock Share Price Data for Long-Term Investment Decisions?

Consider the share price of ADARx Pharmaceuticals, Inc. Common Stock as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether ADARx Pharmaceuticals, Inc. Common Stock has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from ADARx Pharmaceuticals, Inc. Common Stock shares for Indian investors?

When investing in ADARx Pharmaceuticals, Inc. Common Stock shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the ADARx Pharmaceuticals, Inc. Common Stock stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare ADARx Pharmaceuticals, Inc. Common Stock share price with other stocks in the same sector?

Rather than merely checking the share price of ADARx Pharmaceuticals, Inc. Common Stock and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that ADARx Pharmaceuticals, Inc. Common Stock stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.